Venrock Healthcare Capital Partners III, L.P.
SEC Form 4 insider trading activity
Venrock Healthcare Capital Partners III, L.P. has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 27, 2026.
On the most recent filing, Venrock Healthcare Capital Partners III, L.P. is listed as 10% Owner at KalVista Pharmaceuticals, Inc. Inside the rolling window, Venrock Healthcare Capital Partners III, L.P. reported no open-market purchases and 2 open-market sales totaling $3.7M in KALV. The largest disclosed transaction in the window is a sale of 174,645 KALV shares on Mar 25, 2026, worth $3.0M.
Companies traded
Other insiders at KALV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Venrock Healthcare Capital Partners III, L.P. made?
Venrock Healthcare Capital Partners III, L.P. has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company since 2026.
Which companies does Venrock Healthcare Capital Partners III, L.P. trade?
Venrock Healthcare Capital Partners III, L.P. has filed SEC Form 4 disclosures for 1 company, including KALV.
When was Venrock Healthcare Capital Partners III, L.P.'s most recent SEC Form 4 filing?
Venrock Healthcare Capital Partners III, L.P.'s most recent SEC Form 4 filing on Tracefour is dated Mar 27, 2026.
What is Venrock Healthcare Capital Partners III, L.P.'s total buy and sell value in the current window?
Inside the rolling retention window, Venrock Healthcare Capital Partners III, L.P. bought $0 and sold $3.7M based on SEC Form 4 filings.
What was Venrock Healthcare Capital Partners III, L.P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 174,645 KALV shares on 2026-03-25, worth $3.0M, per SEC Form 4 filings.